⌘K

Login Start Free

Home/Filings/4/0001209191-18-021316

4//SEC Filing

COFFMAN ROBERT 4

Accession 0001209191-18-021316

CIK 0001029142other

View on SEC.gov Company Profile

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 5:54 PM ET

Size

5.4 KB

Accession

0001209191-18-021316

Insider Transaction Report

Form 4

Period: 2018-03-21

DYNAVAX TECHNOLOGIES CORPDVAX

Chief Scientific Officer & VP

Transactions

Award
Stock Option (Right to Buy)
2018-03-21+150,000→ 150,000 total
Exercise: $18.40Exp: 2025-03-20→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]50% of this option grant will vest on the second anniversary of the grant date and 50% will vest on the third anniversary of the grant date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

DYNAVAX TECHNOLOGIES CORP

CIK 0001029142

Entity typeother

Related Parties

1

filerCIK 0001278710

Filing Metadata

Form type: 4
Filed: Mar 21, 8:00 PM ET
Accepted: Mar 22, 5:54 PM ET
Size: 5.4 KB

View on SEC.gov